Zydus gets US regulator’s PAS for generic version of Mycophenolate Mofetil for injection
PTI, Mar 21, 2022, 10:46 AM IST
New Delhi: Zydus Lifesciences Ltd on Monday said it has received prior approval supplement nod from the US health regulator to market its generic version of Mycophenolate Mofetil for injection used in combination with other drugs for prophylaxis of organ rejection in patients receiving renal, hepatic or cardiac transplants.
The Prior Approval Supplement (PAS) granted by the US Food & Drug Administration (USFDA) is for Mycophenolate Mofetil for injection of strength 500 mg/vial, the generic equivalent of CellCept injection, the company said in a regulatory filing.
As per the USFDA, PAS refers to a change in either manufacturing or testing of a product applicable to either a specific batch of product or all products that requires the regulator’s approval prior to implementation of such changes or sale of the product.
The company said the PAS it has received is for site transfer into Jarod. ”The injection will be manufactured at the group’s injectables manufacturing facility at Jarod near Vadodara in Gujarat. This site was recently inspected by the USFDA,” it added.
In September 2017, the group was granted approval to market Mycophenolate Mofetil for injection in the strength of 500 mg/vial. Mycophenolate Mofetil is indicated for use in combination with other drugs such as cyclosporine and corticosteroids for the prophylaxis of organ rejection in patients receiving renal, hepatic or cardiac transplants, the company said. The group now has 330 approvals and has so far filed over 400 abbreviated new drug applications since the commencement of the filing process in FY 2003-04, it added.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
‘Faster walkers’ had significantly lower risk of diabetes, hypertension: Study
World Meditation Day 2024: Celebrating inner peace and well-being
Virus causing gut infections could play role in development of Alzheimer’s: Study
Air pollution linked to more hospitalisations for all causes, mental illness too, study finds
Plant-based meat alternatives linked to increased risk of depression in vegetarians, study finds
MUST WATCH
Latest Additions
Kalaburagi: Woman sustains burns after live electric wire falls on her
Nelamangala accident: Police expedite probe, CCTV images being scrutinised
Rohan Estate Mukka – Resort-style luxury layout launched
Minister Parameshwara directs police to ensure tight security in Bengaluru on New Year’s eve
Teachings of Lord Christ celebrate love, harmony: PM Modi at Christmas celebrations
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.